Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy

Indian Journal of Pathology and Microbiology

Volumn 57, Issue 3, 2014, Pages 407-412

  Bajpai, Trupti ^a   Pandey, Maneesha ^b   Varma, Meena ^a   Bhatambare, Ganesh S ^a  

^a SRI AUROBINDO INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIRA GANDHI NATIONAL OPEN UNIVERSITY   (India)

Author keywords

Beta lactam antibiotics; extended spectrum beta lactamase; uropathogens

Indexed keywords

BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ENZYMOLOGY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMAN; INDIA; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PREVALENCE; PROSPECTIVE STUDY; SECRETION (PROCESS); TERTIARY CARE CENTER; URINARY TRACT INFECTIONS;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INDIA; MALE; PREVALENCE; PROSPECTIVE STUDIES; TERTIARY CARE CENTERS; URINARY TRACT INFECTIONS;

EID: 84906774995     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.138733     Document Type: Article

References (39)

1. Mukherjee M, Basu S, Mukherjee SK, Majumder M. Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. Coli which were isolated from hospitalized patients in Kolkata, India. J Clin Diagn Res 2013;7:449-53
2. Krishnakumar S, Rajan RA, Babu MM, Bai VD. Antimicrobial susceptibility pattern of extended spectrum of beta lactamase (ESBL) producing uropathogens from pregnant women. India. J Med Healthcare 2012;1:188-92
3. Aggarwal R, Chaudhary U, Sikka R. Detection of extended spectrum β-lactamase production among uropathogens. J Lab Physicians 2009;1:7-10
4. Yazdi M, Nazemi A, Mirinargasi M, Jafarpour M, Sharifi SH. Genotypic versus Phenotypic methods to detect extended-spectrum betalactamases (ESBLs) in uropathogenic Escherichia coli. Ann Biol Res 2012;3:2454-8
5. Naiemi NA, Murk JL, Savelkoul PH, Vandenbroucke-Grauls CM, Debets- Ossenkopp YJ. Extended-spectrum beta-lactamases screening agar with AmpC inhibition. Eur J Clin Microbiol Infect Dis 2009;28:989-90
6. Collee JG, Fraser AG, Marmian BP, Simmons A, editors. Mackie and McCartney Practical Medical Microbiology. 14th ed. Standard ed. Churchill Livingstone, London, 1996. (Reprinted 1999).
7. Willinger B, Manafi M. Evaluation of a new chromogenic agar medium for the identification of urinary tract pathogens. Lett Appl Microbiol 1995;20:300-5
8. Cheesbrough M. Microbiology. Medical Laboratory Manual for Tropical Countries. Vol. 2. Cambridgeshire, England:1984, p. 985
9. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6
10. Clinical Laboratory Standards Institute. Performance Standard for Antimicrobial Susceptibility Testing. 23rd Information Supplement. NCCLS Document M100-S23. Wayne, PA, USA, 2013
11. Thomson KS. Controversies about extended-spectrum and AmpC betalactamases. Emerg Infect Dis 2001;7:333-6
12. Sasirekha B. Prevalence of ESBL, AMPC B-lactamases and MRSA among uropathogens and its antibiogram. EXCLI J 2013;12:81-8
13. Manjunath GN, Prakash R, Vamseedhar A, Shetty K. Changing trends in the spectrum of antimicrobial drug resiatance pattern of uropathogens isolated from hospitals and community patients with urinary tract infections in Tumkur and Bangalore. Int J Biol Med Res 2011;2:504-7
14. Sood S, Gupta R. Antibiotic resistance pattern of community acquired uropathogens at a tertiary care hospital in Jaipur, Rajasthan. Indian J Community Med 2012;37:39-44
15. Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, et al. Uropathogens and host characteristics. J Clin Microbiol 2008;46:3980-6
16. Ramesh N, Sumathi CS, Balasubramanian V, Palaniappan KR, Kannan VR. Urinary tract infections and antimicrobial susceptibility pattern of extended spectrum of beta lactamase producing clinical isolates. Adv Biol Res 2008;2:78-82
17. Aruna K, Mobashshera T. Prevalence of extended spectrum betalactamase production among uropathogens in South Mumbai and its antibiogram patterns. EXCLI J 2012;11:363-72
18. Gales AC, Sader HS, Jones RN, SENTRY Participants Group (Latin America). Urinary tract infection trends in Latin American hospitals: Report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 2002;44:289-99
19. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002;115:153-7
20. Khurana S, Taneja N, Sharma M. Extended spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 2002;116:145-9
21. Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J Med Res 2004;120:553-6
22. Kumar MS, Lakshmi V, Rajagopalan R. Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Indian J Med Microbiol 2006;24:208-11
23. Taneja N, Rao P, Arora J, Dogra A. Occurrence of ESBL & Amp-C betalactamases & susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res 2008;127:85-8
24. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, et al. Evaluation of methods for AmpC beta-lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 2005;23:120-4
25. Kesavaram P, Krishnan P, Sikhamani R. Detection of Extended-spectrum beta lactamases and AmpC beta-lactamase production in Escherichia coli causing urinary tract infection among HIV and non-HIV patients. Am Med J 2011;2:54-8
26. Maya AS, Prabhakar K, Hanna LE, Sarayu YL. Phenotypic and genotypic characterization of extended-spectrum beta-lactamase producing Escherichia coli clinical isolates from semi-urban area. J Pharm Res 2011;4:6-10
27. Gururajan G, Kathireshan A, Kaliyaperumal, Balagurunathan R. Prevalence of extended spectrum beta lactamases in uro-pathogenic Escherichia coli and Klebsiella species in a Chennai suburban tertiary care hospital and its antibiogram pattern. Res J Microbiol 2011;6:796-804
28. Babypadmini S, Appalaraju B. Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - Prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 2004;22:172-4
29. Ndugulile F, Jureen R, Harthug S, Urassa W, Langeland N. Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania. BMC Infect Dis 2005;5:86
30. Mehrgan H, Rahbar M, Arab-Halvaii Z. High prevalence of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries 2010;4:132-8
31. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006;34:20-8
32. Chaudhary U, Aggarwal R. Extended spectrum -lactamases (ESBL) - An emerging threat to clinical therapeutics. Indian J Med Microbiol 2004;22:75-80
33. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:4
34. Khameneh ZR, Afshar AT. Antimicrobial susceptibility pattern of urinary tract pathogens. Saudi J Kidney Dis Transpl 2009;20:251-3
35. Rajesh KR, Mathavi S, Indra RP. Prevalence of antimicrobial resistance in uropathogens and determining empirical therapy for UTI's. Int J Basic Med Sci 2011;1:260-63
36. Rodríguez-Martínez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53:4783-8
37. Poovendran P, Natarajan V, Murugan S. Antimicrobial susceptibility pattern of ESBL and non-ESBL producing uropathogenic Escherichia coli (UPEC) and their correlation with biofilm formation. Int J Microbiol Res 2013;4:56-63
38. Sasirekha B, Shivakumar S. Occurrence of plasmid-mediated AmpC ?-lactamases among Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care hospital in Bangalore. Indian J Microbiol 2012;52:174-9
39. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res 2006;124:95-8.